Latest Operational Costs News

Alkane Resources reported steady gold production and cash flow for FY2025 at its Tomingley operations, while securing shareholder approval for a transformative merger with Mandalay Resources.

Spectur Limited reported a solid quarter ending June 2025, posting positive net operating cash flow and increasing its cash reserves to over $1 million. The company maintained steady financing arrangements while managing operating costs effectively.

Pilbara Minerals delivered robust FY25 results, completing key expansions and beating production guidance, while setting a cost-focused FY26 plan amid ongoing lithium price volatility.

Pilbara Minerals delivered a standout June quarter with record spodumene production and robust financials, beating FY25 guidance and setting ambitious targets for FY26 amid ongoing market challenges.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

Triangle Energy’s June quarter report reveals a strategic pivot as key JV partners exit, the Cliff Head assets transition to carbon capture, and promising exploration prospects remain in focus.

EcoGraf Limited has advanced its vertically integrated battery anode materials business with a US$105 million financing mandate for its Epanko Graphite Mine and positive momentum in US and EU government support.

Discovery Alaska Limited has terminated its Vinasale Gold Project lease to conserve funds, while maintaining full ownership of the Chulitna Gold Project and exploring new opportunities to boost its portfolio.

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

Liontown Resources reported robust FY25 results with over 294,000 dmt of spodumene concentrate produced and commenced underground mining on schedule. The company is transitioning to 100% underground production by Q3 FY26, aiming for scalable, low-cost operations from FY27 despite a 36% drop in spodumene prices.

Atomo Diagnostics reports strong commercial momentum in Q4 FY25, highlighted by a major US supply agreement, rapid growth in HIV self-test sales, and promising data for its syphilis test.

Spenda Limited has reported a record-breaking FY25 with cash receipts soaring 114% to $11.5 million and launched its APG Pay platform backed by a $50 million funding commitment. The company also trimmed operating costs by 39%, setting a leaner foundation for FY26 growth.